Needham & Company Starts Selecta Biosciences (SELB) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
UBS Starts Selecta Biosciences (SELB) at Buy
July 18, 2016 9:01 AM EDTUBS initiated coverage on Selecta Biosciences (NASDAQ: SELB) with a Buy rating and a price target of $19.00.
For an analyst ratings summary and ratings history on Selecta Biosciences click here. For more ratings news on Selecta Biosciences click here.
Shares of Selecta Biosciences closed at $14.00 yesterday.
... MoreStifel Starts Selecta Biosciences (SELB) at Buy
July 18, 2016 6:19 AM EDTStifel initiates coverage on recent IPO Selecta Biosciences (NASDAQ: SELB) with a Buy rating and a price target of $23.00.
Analyst Thomas Shrader commented, "With our increasing understanding of the molecular control of cellular function comes the increasing opportunity to correct disease states. However, many exciting... More
